Clinical Trial Update: Efficacy and Safety of SmofKabiven Extra Nitrogen for Parenteral Nutrition in Patients Receiving Intensive Care [Phase 3]

View source ↗

Summary

Phase 3 trial update on SmofKabiven Extra Nitrogen for parenteral nutrition in critically ill patients assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Nutrition Therapy

Drugs mentioned

• SmofKabiven Extra Nitrogen (null)

Snippet

Sponsor: Fresenius Kabi | Conditions: Nutrition Therapy, Critical Illness | Phase 3 | Status: COMPLETED